ATProto Browser

ATProto Browser

Experimental browser for the Atmosphere

Post

The diabetes and weight loss drug semaglutide reversed signs of the liver disease MASH, results of a new clinical trial show.

May 7, 2025, 2:30 PM

Record data

{
  "uri": "at://did:plc:mhjqpvjvyzpj4pso7ux2tekh/app.bsky.feed.post/3lolmei5scp2f",
  "cid": "bafyreih4eu5mfwastyapqcrjmktl6is7r5wkqonq7gmh6odqllzb3gt3xi",
  "value": {
    "text": "The diabetes and weight loss drug semaglutide reversed signs of the liver disease MASH, results of a new clinical trial show.",
    "$type": "app.bsky.feed.post",
    "embed": {
      "$type": "app.bsky.embed.external",
      "external": {
        "uri": "https://buff.ly/caz12mF",
        "thumb": {
          "$type": "blob",
          "ref": {
            "$link": "bafkreiauhhlgnhp6qcn4vo23lzjyyggj3z6pif5ozgiahuytyn2mvhuvde"
          },
          "mimeType": "image/jpeg",
          "size": 110500
        },
        "title": "Ozempic and Wegovy ingredient may reverse signs of liver disease",
        "description": "The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH."
      }
    },
    "createdAt": "2025-05-07T14:30:57.510Z"
  }
}